Non-sedative antihistamines: ▾ terfenadine and ▾ astemizole
Author information unavailable
Abstract
Author information unavailable
Abstract
Terfenadine (Triludan - Merrell) and astemizole (Hismanal - Janssen) are two chemically unrelated oral H1-receptor antihistamines marketed recently for the relief of allergic rhinitis, conjunctivitis and other manifestations of histamine release, such as urticaria. Both are claimed to be free of the usual anticholinergic and CNS effects, especially sedation, which limit the use of other H1 antihistamines. If this major claim justified?
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Terfenadine (Triludan - Merrell) and astemizole (Hismanal - Janssen) are two chemically unrelated oral H1-receptor antihistamines marketed recently for the relief of allergic rhinitis, conjunctivitis and other manifestations of histamine release, such as urticaria. Both are claimed to be free of the usual anticholinergic and CNS effects, especially sedation, which limit the use of other H1 antihistamines. If this major claim justified?
Key concepts: Astemizole, Terfenadine, Antihistamine, Histamine H1 receptor, Anticholinergic, Histamine H1 Antagonists, Medicine, Sedative